摘要
N6-methyladenosine (m(6)A) modification has been implicated in the progression of obesity and metabolic diseases. However, its impact on beige fat biology is not well understood. Here, via m(6)A-sequencing and RNA-sequencing, this work reports that upon beige adipocytes activation, glycolytic genes undergo major events of m(6)A modification and transcriptional activation. Genetic ablation of m(6)A writer Mettl3 in fat tissues reveals that Mettl3 deficiency in mature beige adipocytes leads to suppressed glycolytic capability and thermogenesis, as well as reduced preadipocytes proliferation via glycolytic product lactate. In addition, specific modulation of Mettl3 in beige fat via AAV delivery demonstrates consistently Mettl3's role in glucose metabolism, thermogenesis, and beige fat hyperplasia. Mechanistically, Mettl3 and m(6)A reader Igf2bp2 control mRNA stability of key glycolytic genes in beige adipocytes. Overall, these findings highlight the significance of m(6)A on fat biology and systemic energy homeostasis.
学科与关键词
- Mettl3-mediated m6A modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expressionDai, Guanqi; Huang, Shihao; Li, Yonglong; Tu, Xueyi; Xia, Jiawei; Zhou, Zhihao; Chen, Wanyi; Zhang, Ao; Lin, Jintao; Li, Yingchun; He, Danhua; Lin, Taoyan; Cong, Jinge; Lei, Ye; Han, Liuxin; Yao, Zhenxia; Liu, Weiwei; Zhou, Ying; Li, Qiwen; Li, Jing; Zhang, Yuqin; Wu, Aibing; Xiao, Dong*; Wang, Wanshan*; Zhao, Wentao*; Jia, Junshuang*; Lin, Xiaolin*Aging-US, 2023, 15(12): 5550-5568.被引 2
- N6-methyladenosine regulates glycolysis of cancer cells through PDK4Zihan, Li; Yanxi, Peng; Jiexin, Li; Zhuojia, Chen; Feng, Chen; Jian, Tu; Shuibin, Lin; Hongsheng, WangNature Communications, 2020, 11(1): 2578.被引 29
- New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYCCheng, Wenli; Li, Min; Zhang, Luyun; Zhou, Cheng; Yu, Susu; Peng, Xinyue; Zhang, Wenji; Zhang, WenjuanFrontiers in Pharmacology, 2022, 13: 973116.被引 10
